Emergent BioSolutions | EBS - EPS Earnings Per Share


Emergent BioSolutions reported $-0.77 in EPS Earnings Per Share for its fiscal quarter ending in December of 2023.





Eps Change Date
Acadia Pharmaceuticals USD 0.18 0.16 Jun/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
ALKERMES USD 0 0.4 Jun/2026
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
Amarin USD 0.14 0.06 Dec/2025
ANI Pharmaceuticals USD 2.21 0.16 Jun/2026
BioMarin Pharmaceutical USD 1.2 0.44 Jun/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Exelixis USD 0.94 0.03 Sep/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
Ironwood Pharmaceuticals USD 0.31 0.07 Jun/2026
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
Lonza CHF 6.07 1.92 Jun/2025
Merck USD 2.49 2.62 Sep/2026
Moderna USD -1.97 1.43 Jun/2026
Myriad Genetics USD -0.25 0.16 Jun/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Pacira USD 0.73 0.13 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
PTC Therapeutics USD -0.62 1.54 Sep/2026
Sanofi EUR 3.55 1.46 Sep/2026
Sarepta Therapeutics USD 0.64 2.52 Jun/2026
United Therapeutics USD 7.27 1.45 Jun/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024